401 related articles for article (PubMed ID: 23026687)
1. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
Riquelme-Neira R; Retamal-Díaz A; Acuña F; Riquelme P; Rivera A; Sáez D; Oñate A
Vaccine; 2013 Aug; 31(36):3663-7. PubMed ID: 23834811
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
4. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godfroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Oct; 69(10):6264-70. PubMed ID: 11553569
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and Protective Response Induced by Recombinant Plasmids Based on the BAB1_0267 and BAB1_0270 Open Reading Frames of
Gómez LA; Alvarez FI; Fernández PA; Flores MR; Molina RE; Coloma RF; Oñate AA
Front Cell Infect Microbiol; 2016; 6():117. PubMed ID: 27747197
[TBL] [Abstract][Full Text] [Related]
6. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
González-Smith A; Vemulapalli R; Andrews E; Oñate A
Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
[TBL] [Abstract][Full Text] [Related]
8. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
Al-Mariri A
Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
[TBL] [Abstract][Full Text] [Related]
9. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
10. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
12. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.
Hu XD; Chen ST; Li JY; Yu DH; Yi-Zhang ; Cai H
Vaccine; 2010 Mar; 28(12):2408-15. PubMed ID: 20064480
[TBL] [Abstract][Full Text] [Related]
13. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
Gómez L; Alvarez F; Betancur D; Oñate A
Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
Luo D; Ni B; Li P; Shi W; Zhang S; Han Y; Mao L; He Y; Wu Y; Wang X
Infect Immun; 2006 May; 74(5):2734-41. PubMed ID: 16622210
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
17. Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.
Retamal-Díaz A; Riquelme-Neira R; Sáez D; Rivera A; Fernández P; Cabrera A; Guzmán CA; Oñate A
Clin Vaccine Immunol; 2014 Nov; 21(11):1474-80. PubMed ID: 25165025
[TBL] [Abstract][Full Text] [Related]
18. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
Oliveira SC; Harms JS; Banai M; Splitter GA
Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
[TBL] [Abstract][Full Text] [Related]
20. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
